Serum Neurofilament Light (NfL) as a Marker for Brain Injury in Individuals Undergoing Chimeric Antigen Receptor-modified T Therapy

NCT04614987 · clinicaltrials.gov ↗
TERMINATED
Status
17
Enrollment
OTHER
Sponsor class

Stopped PI decided to close study early.

Conditions

Sponsor

Washington University School of Medicine

Collaborators